- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 35/763 - Virus de l’herpès
Détention brevets de la classe A61K 35/763
Brevets de cette classe: 400
Historique des publications depuis 10 ans
|
15
|
28
|
38
|
49
|
72
|
43
|
62
|
32
|
36
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Amgen Inc. | 3902 |
20 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3052 |
19 |
| Virogin Biotech Canada Ltd. | 48 |
19 |
| Replimune Limited | 43 |
16 |
| Krystal Biotech, Inc. | 63 |
15 |
| Alma Mater Studiorum - Universita di Bologna | 393 |
13 |
| The Brigham and Women's Hospital, Inc. | 2146 |
11 |
| Research Institute at Nationwide Children's Hospital | 533 |
8 |
| University of Houston System | 1039 |
8 |
| Virttu Biologics Limited | 18 |
8 |
| Hangzhou Converd Co., Ltd. | 34 |
7 |
| Ohio State Innovation Foundation | 1983 |
6 |
| Oncorus, Inc. | 22 |
6 |
| Gencellmed Inc. | 11 |
6 |
| The Regents of the University of California | 19544 |
5 |
| Benevir Biopharm, Inc. | 9 |
5 |
| New York University | 1687 |
5 |
| The University of Tokyo | 4066 |
5 |
| Xiamen University | 516 |
5 |
| Immvira Co., Limited | 37 |
5 |
| Autres propriétaires | 208 |